BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15384385)

  • 1. Delayed external ventriculoperitoneal shunt infection.
    Owen R; Pittman T
    J Ky Med Assoc; 2004 Aug; 102(8):349-52. PubMed ID: 15384385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of ventriculoperitoneal shunt infections and malfunctions in children with hydrocephalus.
    Lan CC; Wong TT; Chen SJ; Liang ML; Tang RB
    J Microbiol Immunol Infect; 2003 Mar; 36(1):47-50. PubMed ID: 12741733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late ventriculoperitoneal shunt infection caused by Shewanella algae.
    Sardelic S; Karanovic J; Rubic Z; Polic B; Ledenko V; Markic J; Mestrovic J
    Pediatr Infect Dis J; 2010 May; 29(5):475-7. PubMed ID: 19952978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
    von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
    Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postshunt insertion CSF leaks in infants treated by an adjustable valve opening pressure reduction.
    Rohde V; Weinzierl M; Mayfrank L; Gilsbach JM
    Childs Nerv Syst; 2002 Dec; 18(12):702-4. PubMed ID: 12483354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on treatment strategy for ventriculitis associated with ventriculoperitoneal shunt for hydrocephalus].
    Li XY; Wang ZC; Li YP; Ma ZY; Yang J; Cao EC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):558-60. PubMed ID: 16146606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of ceftriaxone versus trimethoprim-sulfamethoxazole to prevent ventriculoperitoneal shunt infection.
    Nejat F; Tajik P; El Khashab M; Kazmi SS; Khotaei GT; Salahesh S
    J Microbiol Immunol Infect; 2008 Apr; 41(2):112-7. PubMed ID: 18473097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid shunt infection.
    Walters BC
    Neurosurg Clin N Am; 1992 Apr; 3(2):387-401. PubMed ID: 1633467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of recurrent ventriculoperitoneal shunt failure associated with persistent cerebrospinal fluid eosinophilia and latex allergy by use of an "extracted" shunt.
    Ellis MJ; Kazina CJ; Del Bigio MR; McDonald PJ
    J Neurosurg Pediatr; 2008 Mar; 1(3):237-9. PubMed ID: 18352769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the complication rate of subduroperitoneal shunt placement for the treatment of subdural hematomas in infants.
    Kurschel S; Puget S; Bourgeois M; Zerah M; Ofner P; Renier D
    J Neurosurg; 2007 Mar; 106(3 Suppl):172-8. PubMed ID: 17465380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventriculoperitoneal shunt infections in patients with hydrocephalus.
    Simpkins CJ
    Pediatr Nurs; 2005; 31(6):457-62. PubMed ID: 16411537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventriculoperitoneal shunt infection: intravenous antibiotics, shunt removal and more aggressive treatment?
    Wong GK; Wong SM; Poon WS
    ANZ J Surg; 2011 Apr; 81(4):307. PubMed ID: 21418491
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic impregnated external ventricular drainage and third ventriculostomy in the management of hydrocephalus associated with posterior cranial fossa tumours.
    Tamburrini G; Massimi L; Caldarelli M; Di Rocco C
    Acta Neurochir (Wien); 2008 Oct; 150(10):1049-55; discussion 1055-6. PubMed ID: 18777004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of spinal wound infections using vacuum-assisted wound closure: risk factors leading to resistance to treatment.
    Ploumis A; Mehbod AA; Dressel TD; Dykes DC; Transfeldt EE; Lonstein JE
    J Spinal Disord Tech; 2008 Jul; 21(5):320-3. PubMed ID: 18600140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycotic complications of shunt infection in children with primary hydrocephalus].
    Kupś J; Woźniakowska-Gesicka T; Grzegorczyk W; Borowska-Rybus B
    Wiad Parazytol; 2002; 48(3):277-86. PubMed ID: 16888973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propionibacterium acnes infection in patients with CSF shunts].
    Bordes A; Elcuaz R; Noguera FJ; Otemin C; Egas G
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):24-7. PubMed ID: 9147504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Shunt nephritis].
    Bilińska W; Rogowska-Kalisz A; Finke D; Nowicki M
    Pol Merkur Lekarski; 2002 Dec; 13(78):500-2. PubMed ID: 12666451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular shunt tap as a predictor of proximal shunt malfunction in children: a prospective study.
    Rocque BG; Lapsiwala S; Iskandar BJ
    J Neurosurg Pediatr; 2008 Jun; 1(6):439-43. PubMed ID: 18518693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-shaved ventriculoperitoneal shunt in Thailand.
    Ratanalert S; Musikawat P; Oearsakul T; Saeheng S; Chowchuvech V
    J Clin Neurosci; 2005 Feb; 12(2):147-9. PubMed ID: 15749415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.